NCT04579757 2025-05-08Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid TumorsHutchmedPhase 1/2 Terminated87 enrolled 29 charts
NCT05527821 2022-09-06Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid TumorsUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 2 Unknown36 enrolled